Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Can J Anaesth ; 62(10): 1055-62, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26272719

RESUMO

BACKGROUND: Short-duration spinal anesthesia is a good option for ambulatory knee surgery. Hyperbaric 2% prilocaine has short onset and rapid recovery times and, therefore, may be well suited in this setting. The aim of this study was to compare the times to reach motor block, motor block resolution, and discharge from the postanesthesia care unit (PACU) between hyperbaric 2% prilocaine and 0.4% plain ropivacaine. METHODS: In this prospective randomized double-blind study, 140 patients (ages 18-80 yr and American Society of Anesthesiologists physical status I-II) scheduled for elective unilateral arthroscopic knee surgery lasting < 45 min were allocated to either 3 mL of 2% prilocaine (60 mg) or 3 mL of 0.4% plain ropivacaine (12 mg). Time to reach complete recovery of motor block, time to reach criteria for discharge, as well as side effects up to 48 hr after discharge were recorded. RESULTS: The median (interquartile range [IQR]) time to recovery from the motor block was faster in the 2% prilocaine group compared with the 0.4% ropivacaine group (180 [169-240] min vs 240 [180-300] min, respectively; median difference, 60 min, 95% confidence interval (CI), 23 to 97 min; P = 0.036). The median [IQR] time to reach discharge criteria was similar between the two groups (330 [295-365] min vs, 335 [290-395] min; median difference 5 min, 95% CI, -25 to 35 min; P = 0.330). The incidence of side effects was low and similar in both groups. No case of transient neurologic symptoms occurred in either group. CONCLUSION: The recovery of motor block was faster after intrathecal administration of hyperbaric 2% prilocaine compared with 0.4% plain ropivacaine; however, discharge time was similar between the two groups. Both drugs showed a similar risk profile.


Assuntos
Amidas/administração & dosagem , Anestésicos Locais/administração & dosagem , Artroscopia/métodos , Prilocaína/administração & dosagem , Adulto , Idoso , Procedimentos Cirúrgicos Ambulatórios/métodos , Amidas/efeitos adversos , Período de Recuperação da Anestesia , Raquianestesia/efeitos adversos , Raquianestesia/métodos , Anestésicos Locais/efeitos adversos , Método Duplo-Cego , Feminino , Humanos , Injeções Espinhais , Articulação do Joelho/cirurgia , Masculino , Pessoa de Meia-Idade , Bloqueio Nervoso/efeitos adversos , Bloqueio Nervoso/métodos , Prilocaína/efeitos adversos , Estudos Prospectivos , Ropivacaina
2.
Anesth Analg ; 111(6): 1543-7, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20889941

RESUMO

BACKGROUND: Interscalene analgesia is a recognized technique for the management of postoperative pain after major shoulder surgery. The most effective local anesthetic concentration in this setting is still controversial. In this study, we compared the analgesia and side effects of a continuous infusion of ropivacaine 0.2% and 0.3% administered through an interscalene catheter for the first 48 hours after surgery. METHODS: Eighty consecutive patients scheduled for elective open rotator cuff repair were randomized into 2 groups to receive a continuous infusion of either ropivacaine 0.2% or ropivacaine 0.3% for 48 hours at a rate of 14 mL/h through an interscalene catheter after a preoperative bolus of 40 mL ropivacaine 0.5% in all patients. Pain score (visual analog scale 0-100), intensity of motor block, quality of sleep during the first postoperative night, morphine consumption, side effects, and patient satisfaction were assessed by an anesthesiologist masked to treatment group. RESULTS: Total morphine consumption was significantly reduced in group 0.3% (12 vs 30 mg). Quality of sleep was significantly better in group 0.3% (4% vs 27% of awakening during the first postoperative night). Handgrip strength, visual analog scale scores, and side effects were similar in both groups. CONCLUSION: The use of ropivacaine 0.3% through an interscalene catheter for the first 48 hours after open rotator cuff repair provided a significant reduction of morphine consumption and a better sleep quality for the first postoperative night without increasing the intensity of motor block or side effects.


Assuntos
Amidas/administração & dosagem , Analgesia/métodos , Anestésicos Locais/administração & dosagem , Neurônios Motores/efeitos dos fármacos , Bloqueio Nervoso , Procedimentos Ortopédicos , Dor Pós-Operatória/prevenção & controle , Manguito Rotador/cirurgia , Adulto , Amidas/efeitos adversos , Analgesia/efeitos adversos , Analgésicos Opioides/administração & dosagem , Anestésicos Locais/efeitos adversos , Cateterismo , Feminino , Força da Mão , Humanos , Masculino , Pessoa de Meia-Idade , Morfina/administração & dosagem , Bloqueio Nervoso/efeitos adversos , Procedimentos Ortopédicos/efeitos adversos , Medição da Dor , Dor Pós-Operatória/etiologia , Satisfação do Paciente , Recuperação de Função Fisiológica , Ropivacaina , Manguito Rotador/inervação , Manguito Rotador/fisiopatologia , Sono/efeitos dos fármacos , Inquéritos e Questionários , Suíça , Fatores de Tempo , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...